156 related articles for article (PubMed ID: 12932788)
1. Molecular determinants of LXRalpha agonism.
Wang M; Thomas J; Burris TP; Schkeryantz J; Michael LF
J Mol Graph Model; 2003 Nov; 22(2):173-81. PubMed ID: 12932788
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
3. The important role of residue F268 in ligand binding by LXRbeta.
Urban F; Cavazos G; Dunbar J; Tan B; Escher P; Tafuri S; Wang M
FEBS Lett; 2000 Nov; 484(2):159-63. PubMed ID: 11068052
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.
Spencer TA; Li D; Russel JS; Collins JL; Bledsoe RK; Consler TG; Moore LB; Galardi CM; McKee DD; Moore JT; Watson MA; Parks DJ; Lambert MH; Willson TM
J Med Chem; 2001 Mar; 44(6):886-97. PubMed ID: 11300870
[TBL] [Abstract][Full Text] [Related]
5. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands.
Färnegårdh M; Bonn T; Sun S; Ljunggren J; Ahola H; Wilhelmsson A; Gustafsson JA; Carlquist M
J Biol Chem; 2003 Oct; 278(40):38821-8. PubMed ID: 12819202
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor beta with mutations in the activation function-2 region is excluded from the nucleolus.
Lall R; Kuruvilla S; Prüfer K
Cell Biol Int; 2009 Mar; 33(3):447-52. PubMed ID: 19356704
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and initial structural characterization of rat orphan nuclear receptor NOR-1 LBD domain.
Razzera G; Vernal J; Portugal RV; Calgaro MR; Fernandez P; Zakin MM; Polikarpov I; Terenzi H
Protein Expr Purif; 2004 Oct; 37(2):443-9. PubMed ID: 15358368
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
Gbaguidi GF; Agellon LB
Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
11. Analysis of crystal structures of LXRbeta in relation to plasticity of the ligand-binding domain upon ligand binding.
Malini N; Rajesh H; Berwal P; Phukan S; Balaji VN
Chem Biol Drug Des; 2008 Feb; 71(2):140-54. PubMed ID: 18221307
[TBL] [Abstract][Full Text] [Related]
12. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.
Janowski BA; Grogan MJ; Jones SA; Wisely GB; Kliewer SA; Corey EJ; Mangelsdorf DJ
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):266-71. PubMed ID: 9874807
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and function of alternative splicing variants of human liver X receptor α.
Endo-Umeda K; Uno S; Fujimori K; Naito Y; Saito K; Yamagishi K; Jeong Y; Miyachi H; Tokiwa H; Yamada S; Makishima M
Mol Pharmacol; 2012 Jun; 81(6):800-10. PubMed ID: 22399489
[TBL] [Abstract][Full Text] [Related]
15. Ligand specificity and evolution of liver X receptors.
Reschly EJ; Ai N; Welsh WJ; Ekins S; Hagey LR; Krasowski MD
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):83-94. PubMed ID: 18395439
[TBL] [Abstract][Full Text] [Related]
16. CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor.
Shenoy SD; Spencer TA; Mercer-Haines NA; Alipour M; Gargano MD; Runge-Morris M; Kocarek TA
Drug Metab Dispos; 2004 Jan; 32(1):66-71. PubMed ID: 14709622
[TBL] [Abstract][Full Text] [Related]
17. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
[TBL] [Abstract][Full Text] [Related]
18. Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.
Matsusue K; Miyoshi A; Yamano S; Gonzalez FJ
Mol Cell Endocrinol; 2006 Aug; 256(1-2):23-33. PubMed ID: 16806672
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid response and promoter occupancy of the mouse LXRalpha gene.
Steffensen KR; Holter E; Alikhani N; Eskild W; Gustafsson JA
Biochem Biophys Res Commun; 2003 Dec; 312(3):716-24. PubMed ID: 14680824
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
